Literature DB >> 28925390

Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes.

A Mizrahi1, A Barzilai2, D Gur-Wahnon3, I Z Ben-Dov3, S Glassberg1, T Meningher1, E Elharar1, M Masalha1,4, J Jacob-Hirsch5, H Tabibian-Keissar6,7, I Barshack4,7, J Roszik8,9, R Leibowitz-Amit4,10, Y Sidi1,4, D Avni1.   

Abstract

Skin carcinogenesis is known to be a multi-step process with several stages along its malignant evolution. We hypothesized that transformation of normal epidermis to cutaneous squamous cell carcinoma (cSCC) is causally linked to alterations in microRNAs (miRNA) expression. For this end we decided to evaluate their alterations in the pathologic states ending in cSCC. Total RNA was extracted from formalin fixed paraffin embedded biopsies of five stages along the malignant evolution of keratinocytes towards cSCC: Normal epidermis, solar elastosis, actinic keratosis KIN1-2, advanced actinic keratosis KIN3 and well-differentiated cSCC. Next-generation small RNA sequencing was performed. We found that 18 miRNAs are overexpressed and 28 miRNAs are underexpressed in cSCC compared to normal epidermis. miR-424, miR-320, miR-222 and miR-15a showed the highest fold change among the overexpressed miRNAs. And miR-100, miR-101 and miR-497 showed the highest fold change among the underexpressed miRNAs. Heat map of hierarchical clustering analysis of significantly changed miRNAs and principle component analysis disclosed that the most prominent change in miRNAs expression occurred in the switch from 'early' stages; normal epidermis, solar elastosis and early actinic keratosis to the 'late' stages of epidermal carcinogenesis; late actinic keratosis and cSCC. We found several miRNAs with 'stage specific' alterations while others display a clear 'gradual', either progressive increase or decrease in expression along the malignant evolution of keratinocytes. The observed alterations focused in miRNAs involved in the regulation of AKT/mTOR or in those involved in epithelial to mesenchymal transition. We chose to concentrate on the evaluation of the molecular role of miR-497. We found that it induces reversion of epithelial to mesenchymal transition. We proved that SERPINE-1 is its biochemical target. The present study allows us to further study the pathways that are regulated by miRNAs along the malignant evolution of keratinocytes towards cSCC.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28925390     DOI: 10.1038/onc.2017.315

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  80 in total

Review 1.  The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.

Authors:  Lakshmanane Boominathan
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

2.  [Solar elastosis in cutaneous squamous cell carcinoma].

Authors:  R Corbalán-Vélez; J A Ruiz-Macia; C Brufau; I Oviedo-Ramírez; E Martínez-Barba; J M López-Lozano; F J Carapeto
Journal:  Actas Dermosifiliogr       Date:  2010-07

Review 3.  MicroRNA control of epithelial-mesenchymal transition and metastasis.

Authors:  Jinsong Zhang; Li Ma
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

4.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

5.  The Role of miR-497/EIF3A Axis in TGFβ1-Induced Epithelial-Mesenchymal Transition and Extracellular Matrix in Rat Alveolar Epithelial Cells and Pulmonary Fibroblasts.

Authors:  Ren Guo; Yu Lv; Yang Ouyang; Siyu Liu; Dai Li
Journal:  J Cell Biochem       Date:  2017-05-03       Impact factor: 4.429

6.  MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer.

Authors:  Hou-Gang Huang; Xi Luo; Shuai Wu; Bin Jian
Journal:  Asian Pac J Cancer Prev       Date:  2015

7.  MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.

Authors:  Min Luo; Dongxiang Shen; Xiaoning Zhou; Xiaodong Chen; Wei Wang
Journal:  Surgery       Date:  2013-02-28       Impact factor: 3.982

8.  Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas.

Authors:  J G Rheinwald; M A Beckett
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

Review 9.  TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis.

Authors:  Panagiotis Papageorgis
Journal:  J Oncol       Date:  2015-03-25       Impact factor: 4.375

10.  MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells.

Authors:  Aoxue Wang; Ning Xu Landén; Florian Meisgen; Warangkana Lohcharoenkal; Mona Ståhle; Enikö Sonkoly; Andor Pivarcsi
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

View more
  17 in total

1.  RNA-Seq Profiling of Circular RNAs and the Oncogenic Role of circPVT1 in Cutaneous Squamous Cell Carcinoma.

Authors:  Shuang Chen; Junli Ding; Yunlin Wang; Tao Lu; Lili Wang; Xinghua Gao; Hongduo Chen; Le Qu; Chundi He
Journal:  Onco Targets Ther       Date:  2020-07-12       Impact factor: 4.147

2.  TAp63-Regulated miRNAs Suppress Cutaneous Squamous Cell Carcinoma through Inhibition of a Network of Cell-Cycle Genes.

Authors:  Andrew John Davis; Maksym Tsinkevich; Jason Rodencal; Hussein A Abbas; Xiao-Hua Su; Young-Jin Gi; Bin Fang; Kimal Rajapakshe; Cristian Coarfa; Preethi H Gunaratne; John M Koomen; Kenneth Y Tsai; Elsa R Flores
Journal:  Cancer Res       Date:  2020-03-10       Impact factor: 12.701

Review 3.  A Review of the Literature of Surgical and Nonsurgical Treatments of Invasive Squamous Cells Carcinoma.

Authors:  Concetta Potenza; Nicoletta Bernardini; Veronica Balduzzi; Luigi Losco; Alessandra Mambrin; Anna Marchesiello; Ersilia Tolino; Sara Zuber; Nevena Skroza; Ilaria Proietti
Journal:  Biomed Res Int       Date:  2018-04-02       Impact factor: 3.411

4.  The role of LINC00094/miR-224-5p (miR-497-5p)/Endophilin-1 axis in Memantine mediated protective effects on blood-brain barrier in AD microenvironment.

Authors:  Lu Zhu; Meiqing Lin; Jun Ma; Wenjing Liu; Lili Gao; Shanshan Wei; Yixue Xue; Xiuli Shang
Journal:  J Cell Mol Med       Date:  2019-02-22       Impact factor: 5.310

5.  MicroRNA-96-3p promotes metastasis of papillary thyroid cancer through targeting SDHB.

Authors:  Xupeng Zhao; Yingjie Li; Yong Zhou
Journal:  Cancer Cell Int       Date:  2019-11-12       Impact factor: 5.722

6.  miRNA-mRNA Associated With Survival in Endometrial Cancer.

Authors:  Xiaofeng Xu; Tao Liu; Yijin Wang; Jian Fu; Qian Yang; Jun Wu; Huaijun Zhou
Journal:  Front Genet       Date:  2019-08-20       Impact factor: 4.599

7.  Distinguishing Tumor and Stromal Sources of MicroRNAs Linked to Metastasis in Cutaneous Melanoma.

Authors:  Kathleen Watt; Kathrin Tyryshkin; Neil Renwick; Andrew W B Craig
Journal:  Transl Oncol       Date:  2020-05-28       Impact factor: 4.243

8.  Uncommon Presentation of Metastatic Squamous Cell Carcinoma of the Skin and Treatment Challenges.

Authors:  Anita Pandey; Maksim Liaukovich; Kishor Joshi; Boris I Avezbakiyev; James E O'Donnell
Journal:  Am J Case Rep       Date:  2019-03-06

Review 9.  MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.

Authors:  Natalia García-Sancha; Roberto Corchado-Cobos; Jesús Pérez-Losada; Javier Cañueto
Journal:  Int J Mol Sci       Date:  2019-05-02       Impact factor: 5.923

10.  miR-424-5p Promotes Anoikis Resistance and Lung Metastasis by Inactivating Hippo Signaling in Thyroid Cancer.

Authors:  Xiaoli Liu; Yantao Fu; Guang Zhang; Daqi Zhang; Nan Liang; Fang Li; Changlin Li; Chengqiu Sui; Jinxi Jiang; Hongzhi Lu; Zihan Zhao; Gianlorenzo Dionigi; Hui Sun
Journal:  Mol Ther Oncolytics       Date:  2019-11-13       Impact factor: 7.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.